Biomedical Sciences and Chinese Medicine, School of Biological Sciences, Nanyang Technological University, Singapore, 637551, Singapore.
Hong Kong Chinese Medicine Clinical Study Centre, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Hong Kong SAR, China.
BMC Psychiatry. 2023 May 4;23(1):314. doi: 10.1186/s12888-023-04749-1.
Patients with post-stroke depression (PSD) usually experience anxiety, hopelessness, and insomnia, which have a negative impact on their daily activities and post-stroke rehabilitation. Acupuncture (AC), as a minimally invasive technique, has become a popular choice for improving depression symptoms. However, it is still unclear which therapy is associated with the best outcomes for PSD. In this review, we aimed to explore the impact of AC in alleviating symptoms of PSD and to evaluate the difference in effectiveness between AC combined with pharmacotherapies and various non-pharmacotherapies.
Six databases and three clinical trials registration platforms were searched from inception to March 2023. Randomized clinical trial comparing needle-based AC with pharmacotherapy, and other non-pharmacotherapy or invalid group were included. Two independent reviewers identified eligible studies, and collected data using a pre-made form. A Bayesian network meta-analysis was conducted to assess and compare different techniques using RStudio 3.6.0 with the package 'GEMTC' V.0.8.1. The primary outcome was the efficacy for PSD assessed by scales measuring depressive symptoms. The secondary outcomes were effectiveness for neurological function and the quality of life. The ranking probabilities for all treatment interventions was performed using the Surface Under the Cumulative Ranking curve (SUCRA). The risk of bias was assessed by using the Revised Cochrane Risk of Bias tool 2.
Sixty-two studies, involving 5308 participants published from 2003 to 2022, were included. The results showed that compared with western medicine (WM) (defined as pharmacotherapy for PSD), AC alone or with repetitive transcranial magnetic stimulation (RTMS), Traditional Chinese medicine (TCM) alone or with WM, were superior for alleviating depression symptoms. Compared to Usual Care, AC alone or plus other therapies could significantly decrease scores on the Hamilton Depression Rating scale. According to result of SUCRA, AC plus RTMS had the highest probability of improving depressive symptoms with a probability of 49.43%.
The results of this study indicate that AC alone or combined with other therapies appears to be effective in improving depression symptoms of stroke survivors. Moreover, in comparison to WM, AC alone or plus RTMS, TCM, TCM with WM, or WM, were more effective in improving depression symptoms of PSD. Also, AC with RTMS seems to be the most effective with the highest probability.
This study was registered in the International Prospective Register of Systematic Reviews (PROSPERO) database in November 2020 and updated in July 2021. The registration number is CRD42020218752.
中风后抑郁(PSD)患者通常会出现焦虑、绝望和失眠等症状,这些症状会对他们的日常活动和中风后的康复产生负面影响。针刺(AC)作为一种微创技术,已成为改善抑郁症状的热门选择。然而,目前尚不清楚哪种疗法对 PSD 的疗效最好。在这项综述中,我们旨在探讨 AC 对缓解 PSD 症状的影响,并评估 AC 联合药物治疗与各种非药物治疗之间的疗效差异。
从建库到 2023 年 3 月,我们在六个数据库和三个临床试验注册平台上进行了检索。纳入了比较基于针的 AC 与药物治疗、其他非药物治疗或无效组的随机临床试验。两名独立的审查员确定了合格的研究,并使用预制作的表格收集数据。使用 RStudio 3.6.0 中的“GEMTC”V.0.8.1 包进行贝叶斯网络荟萃分析,以评估和比较不同技术。主要结局是使用评估抑郁症状的量表测量 PSD 的疗效。次要结局是神经功能和生活质量的疗效。使用累积排序曲线下面积(SUCRA)对所有治疗干预的排序概率进行分析。使用修订后的 Cochrane 偏倚风险工具 2 评估偏倚风险。
从 2003 年至 2022 年共纳入了 62 项研究,涉及 5308 名参与者。结果表明,与西药(WM)(定义为 PSD 的药物治疗)相比,AC 单独或与重复经颅磁刺激(RTMS)联合、中药(TCM)单独或与 WM 联合治疗在缓解抑郁症状方面更有效。与常规护理相比,AC 单独或加用其他疗法可显著降低汉密尔顿抑郁评定量表的评分。根据 SUCRA 的结果,AC 加 RTMS 改善抑郁症状的概率最高,为 49.43%。
本研究结果表明,AC 单独或联合其他疗法似乎可有效改善中风幸存者的抑郁症状。此外,与 WM 相比,AC 单独或加用 RTMS、TCM、WM 加 TCM 或 WM 更能改善 PSD 的抑郁症状。而且,AC 加 RTMS 似乎是最有效的,概率最高。
本研究于 2020 年 11 月在国际前瞻性系统评价注册库(PROSPERO)进行了注册,并于 2021 年 7 月进行了更新。注册号为 CRD42020218752。